KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Depreciation and Depletion (2016 - 2019)

Elevance Health (ELV) has disclosed Depreciation and Depletion for 12 consecutive years, with $67.0 million as the latest value for Q4 2020.

  • On a quarterly basis, Depreciation and Depletion changed N/A to $67.0 million in Q4 2020 year-over-year; TTM through Dec 2020 was $176.0 million, a N/A change, with the full-year FY2025 number at $94.0 million, down 10.48% from a year prior.
  • Depreciation and Depletion was $67.0 million for Q4 2020 at Elevance Health, up from $38.0 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $67.0 million in Q4 2020 to a low of $25.6 million in Q1 2016.
  • A 5-year average of $32.2 million and a median of $29.5 million in 2017 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: decreased 6.14% in 2016, then rose 22.58% in 2019.
  • Elevance Health's Depreciation and Depletion stood at $26.3 million in 2016, then grew by 10.27% to $29.0 million in 2017, then increased by 10.34% to $32.0 million in 2018, then rose by 18.75% to $38.0 million in 2019, then skyrocketed by 76.32% to $67.0 million in 2020.
  • Per Business Quant, the three most recent readings for ELV's Depreciation and Depletion are $67.0 million (Q4 2020), $38.0 million (Q3 2019), and $37.0 million (Q2 2019).